Clients
Who we work with.
AlaBioPharma engages with biotechs, mid-cap pharmaceuticals, foundations, and investment teams. We accept a small number of new engagements each year, and we are direct about whether the fit is right.
Emerging Biotech
Venture-backed sponsors approaching first-in-human
Pre-IND through Phase 1 strategy. We act as fractional senior pharmacology or regulatory lead, available to investors and the board, embedded in the science of the program.
Mid-Cap Pharmaceutical
Internal program reviews and second opinions
Independent senior counsel for internal go / no-go decisions, abuse-liability strategy, and CNS-specific program reviews. Engagements are usually scoped around a single decision point.
Foundations and Academics
Foundation-funded discovery and translational programs
Standing scientific advisor and grant-review support for disease foundations and academic translational programs. Reduced rate structure for non-commercial work.
Investors and Boards
Scientific diligence for licensing, financing, and acquisition
Independent scientific diligence engagements for venture, growth, and corporate development teams. We read the data, identify the questions the deck does not answer, and put our name on the memo.
"Brought the kind of senior scientific judgment that you cannot manufacture on a deadline. Asked the question we should have asked, three years earlier."
Chief Medical Officer, CNS-focused biotech
Let's begin the conversation
We work with a small number of clients each year so that every engagement gets the focus it deserves. Tell us about the molecule, the program, or the question on the table.